摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-叠氮基-5-脱氧胸腺嘧啶脱氧核苷 | 19316-85-9

中文名称
5-叠氮基-5-脱氧胸腺嘧啶脱氧核苷
中文别名
5'-叠氮基-5'-脱氧胸苷
英文名称
5'-azido-5'-deoxythymidine
英文别名
5’-azido-5’-deoxythymidine;5′-azido-5′-deoxythymidine;Thymidine, 5'-azido-5'-deoxy-;1-[(2R,4S,5R)-5-(azidomethyl)-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione
5-叠氮基-5-脱氧胸腺嘧啶脱氧核苷化学式
CAS
19316-85-9
化学式
C10H13N5O4
mdl
——
分子量
267.244
InChiKey
GKEHVJFBPNPCKI-XLPZGREQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    164-166℃

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    93.2
  • 氢给体数:
    2
  • 氢受体数:
    6

SDS

SDS:925a98e5b11bde04b50475bb5da4f170
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8

反应信息

  • 作为反应物:
    描述:
    5-叠氮基-5-脱氧胸腺嘧啶脱氧核苷 在 palladium on activated charcoal 4-二甲氨基吡啶氢气三乙胺 作用下, 以 吡啶乙醇 为溶剂, 反应 8.0h, 生成 5'-monomethoxytritylamino-2',5'-dideoxythymidine
    参考文献:
    名称:
    含氨基磷酸酯核苷酸间键合的寡脱氧核苷酸的固相合成及其特异性化学裂解
    摘要:
    带有氨基磷酸酯核苷酸间键的寡核苷酸可以通过标准的固相DNA合成进行化学制备。因此,可以将氨基磷酸酯核苷酸间键随意放置在给定DNA片段内的特定位置。以这种方式制备的经骨架修饰的DNA片段易受特定化学裂解的影响。
    DOI:
    10.1002/hlca.19880710618
  • 作为产物:
    描述:
    beta-胸苷 在 sodium azide 作用下, 以 吡啶二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 3.5h, 生成 5-叠氮基-5-脱氧胸腺嘧啶脱氧核苷
    参考文献:
    名称:
    New [(η5-C5H5)Ru(N–N)(PPh3)][PF6] compounds: colon anticancer activity and GLUT-mediated cellular uptake of carbohydrate-appended complexes
    摘要:
    钌糖基共轭物,通过葡萄糖转运体优先穿过HCT116结肠癌细胞膜,有报道。
    DOI:
    10.1039/c6dt01571a
点击查看最新优质反应信息

文献信息

  • A new way to do an old reaction: highly efficient reduction of organic azides by sodium iodide in the presence of acidic ion exchange resin
    作者:Kajitha Suthagar、Antony J. Fairbanks
    DOI:10.1039/c6cc08574a
    日期:——
    Organic azides are readily reduced to the corresponding amines by treatment with sodium iodide in the presence of acidic ion exchange resin. The process, optimal when performed at 40 oC...
    通过在酸性离子交换树脂的存在下用碘化钠处理,有机叠氮化物容易还原为相应的胺。该过程在40 oC下执行时最佳...
  • A hydroxamic-acid-containing nucleoside inhibits DNA repair nuclease SNM1A
    作者:William Doherty、Eva-Maria Dürr、Hannah T. Baddock、Sook Y. Lee、Peter J. McHugh、Tom Brown、Mathias O. Senge、Eoin M. Scanlan、Joanna F. McGouran
    DOI:10.1039/c9ob01133a
    日期:——
    synthesised and evaluated as inhibitors of the DNA repair nuclease SNM1A. The series included oxyamides, hydroxamic acids, hydroxamates, a hydrazide, a squarate ester and a squaramide. A hydroxamic acid-derived nucleoside inhibited the enzyme, offering a novel approach for potential therapeutic development through the use of rationally designed nucleoside derived inhibitors.
    九个修饰的核苷,结合锌结合药效基团,已经合成并评估为DNA修复核酸酶SNM1A的抑制剂。该系列包括氧酰胺,异羟肟酸,异羟肟酸酯,酰肼,方酸酯和方酰胺。异羟肟酸衍生的核苷抑制了该酶,通过使用合理设计的核苷衍生的抑制剂为潜在的治疗开发提供了一种新方法。
  • Antisense molecules and method of controlling expression of gene function by using the same
    申请人:——
    公开号:US20030162739A1
    公开(公告)日:2003-08-28
    An antisense molecule which acts on both directions of the inhibition and expression of a gene function and is capable of on-off switching of a gene function appropriately depending on the external factors (orientation controlling factors); and a method for reversibly controlling the expression of a gene function by using the antisense molecule. Such an antisense molecule, which has at least one sugar-base moiety consisting of sugar and a purine or pyrimidine base bonded thereto via a glucoside bond, can bind to a mRNA/gene and/or dissociate therefrom under the orientation control of the base moiety in the molecule by the orientation controlling factors.
    一种反义分子,可以作用于基因功能的抑制和表达的两个方向,并且能够根据外部因素(定向控制因子)适当地开关基因功能;以及一种通过使用该反义分子可逆地控制基因功能表达的方法。这样的反义分子至少包含一个由糖和通过葡苷键连接到糖上的嘌呤或嘧啶碱基部分,可以通过分子中碱基部分的定向控制因子的定向控制,结合到mRNA/基因上,和/或从中解离。
  • Nucleoside derivatives
    申请人:——
    公开号:US20030208050A1
    公开(公告)日:2003-11-06
    Novel nucleoside derivatives represented by the following general formula (1): 1 wherein X is(are) the same or different and each represents a pyrimidine or purine base or a derivative thereof, Y-and Y′ are the same or different and each represents at least one amino acid or amino acid derivative selected from the group consisting of serine, threonine, ornithine, aspartic acid, glutamic acid, lysine, arginine, cysteine, methionine, &dgr;-hydroxylysine, N-aminoethylglycine, N-aminoethylserine, N-aminoethyllysine, N-aminoethylornithine, N-aminoethylaspartic acid, N-aminoethylglutamic acid, homoglutamic acid, &bgr;-thiocarbonylaspartic acid, &ggr;-thiocarbonylglutamic acid, and &dgr;-thiocarbonylhomoglutamic acid, R 1 represents a hydrogen atom or a hydroxyl group, A represents a single bond or a carbonyl or thiocarbonyl group, 1 is an integer of 0 to 5, and n is an integer of 1 to 100.
    以下是通用公式(1)所代表的新型核苷衍生物: 其中X是相同或不同的,每个代表嘧啶或嘌呤碱基或其衍生物,Y和Y'是相同或不同的,每个代表丝氨酸、苏氨酸、鸟氨酸、天冬氨酸、谷氨酸、赖氨酸、精氨酸、半胱氨酸、蛋氨酸、δ-羟基赖氨酸、N-氨基乙基甘氨酸、N-氨基乙基丝氨酸、N-氨基乙基赖氨酸、N-氨基乙基鸟氨酸、N-氨基乙基天冬氨酸、N-氨基乙基谷氨酸、同谷氨酸、β-硫代羰基天冬氨酸、γ-硫代羰基谷氨酸和δ-硫代羰基同谷氨酸,R1代表氢原子或羟基,A代表单键或羰基或硫代羰基,1是0到5的整数,n是1到100的整数。
  • Design, Synthesis and Biological Evaluation of Novel Anthraniloyl-AMP Mimics as PQS Biosynthesis Inhibitors Against Pseudomonas aeruginosa Resistance
    作者:Shekh Sabir、Sujatha Subramoni、Theerthankar Das、David StC. Black、Scott A. Rice、Naresh Kumar
    DOI:10.3390/molecules25133103
    日期:——
    therefore, it is an attractive target for the development of anti-virulence therapeutics against Pseudomonas resistance. Herein, we report the design and synthesis of novel triazole nucleoside-based anthraniloyl- adenosine monophosphate (AMP) mimics. These analogues had a major impact on the morphology of bacterial biofilms and caused significant reduction in bacterial aggregation and population density
    假单胞菌喹诺酮系统 (PQS) 是铜绿假单胞菌中三个主要相互连接的群体感应信号系统之一。毒力因子 PQS 和 HHQ 激活转录调节因子 PqsR (MvfR),它控制细菌中的多种活动,包括生物膜形成和 PQS 生物合成的上调。邻氨基苯甲酰辅酶A合成酶(PqsA)催化喹诺酮类生物合成的第一步和关键步骤;因此,它是开发针对假单胞菌耐药性的抗毒力疗法的一个有吸引力的目标。在此,我们报告了基于三唑核苷的新型邻氨基苯甲酰腺苷单磷酸 (AMP) 模拟物的设计和合成。这些类似物对细菌生物膜的形态有重大影响,并导致细菌聚集和种群密度显着降低。然而,这些化合物对 PQS 的抑制作用有限,对绿脓素的产生没有任何影响。
查看更多

同类化合物

鲁西他滨 化合物 T14195 [1,1'-联苯基]-2,3,3',4,4',5'-六醇 [(2R,3R,5S)-3-(氨基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]N-[[(2R,3S,5R)-3-羟基-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]甲基]氨基甲酸酯 9-(2-S-苯甲基-5-脱氧-2-硫代五呋喃糖基)-9H-嘌呤-6-胺 5-脱氧胸苷 5-脱氧-5-[(碘乙酰基)氨基]-胸腺嘧啶脱氧核苷 5-碘-5-脱氧胸腺嘧啶脱氧核苷 5-氨基-5-脱氧胸腺嘧啶脱氧核苷 5-氨基-2,5-二脱氧腺苷酸 5-叠氮基-5-脱氧胸腺嘧啶脱氧核苷 5-三氟乙酰氨基-5-脱氧胸腺嘧啶脱氧核苷 5'-脱氧-5'氟胸苷 5'-脱氧-5'-{[4-(甲硫基)苯胺基羰基]氨基}胸苷 5'-脱氧-5'-{[3-(甲硫基)苯胺基羰基]氨基}胸苷 5'-脱氧-5'-[4-苯基-(1,2,3)三唑-1-基]胸苷 5'-脱氧-5'-[4-(吡啶-3-基)-(1,2,3)三唑-1-基]胸苷 5'-脱氧-5'-[4-(4-氟苯基)-(1,2,3)三唑-1-基]胸苷 5'-硫代-胸苷3',5'-二乙酸酯 5'-溴乙酰氨基-5'-脱氧胸苷 5'-氨基-5-碘-2',5'-二脱氧尿苷 2-氯-N-[[3-羟基-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]甲基]乙酰胺 2,5-二脱氧腺苷 2',5'-二脱氧尿苷 1-[(2R,4S,5R)-4-羟基-5-(异氰基甲基)四氢呋喃-2-基]嘧啶-2,4-二酮 1-[(2R,4S,5R)-4-羟基-5-(异氰基甲基)四氢呋喃-2-基]-5-甲基嘧啶-2,4-二酮 1-(2,5-二脱氧-2-氟-β-D-呋喃阿拉伯糖基)嘧啶-2,4(1H,3H)-二酮 1-(2,5-二脱氧-2-氟-β-D-呋喃阿拉伯糖基)-5-碘嘧啶-2,4(1H,3H)-二酮 1-citosin-1-yl-1,2,5-trideoxy-α-L-threo-pentofuranos-4-yloxymethylphosphonic acid 9-[2,5-dideoxy-2-fluoro-5-[N-(N-2-hydroxybenzoyl)sulfamoyl]amino-β-D-ribofuranosyl]adenine triethylammonium salt 5'-amino-2',5'-dideoxy-2'-fuorouridine 1-(5'-deoxythymidin-5'-yl)-4-[methyloxycarbonyl-(2'-deoxy-2',2'-difluorocytidin-4N-yl)]-1H-1,2,3-triazole 2',5'-dideoxy-2'-(3,5-dimethoxybenzamido)-5'-(cyclohexylacetamido)adenosine 2',5'-dideoxy-2'-(3'',5''-dimethoxybenzamido)-5'-(diphenylacetamido)adenosine 2',5'-dideoxy-5'-(hydroxyethylthio)adenosine 1-(5-azido-2,5-dideoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethyluracil 1-(5'-deoxythymidin-5'-yl)-4-[methyl-(2'-deoxy-2',2'-difluorocytidin-4N-yl)]-1H-1,2,3-triazole 4′-C-azidomethyl-2′-deoxy-2′-fluorouridine 2',5'-dideoxy-6-thioguanosine thymidylyl (3'-5') 5'-seleno-5'-deoxythymidine 3'-O-(t-butyldimethylsilyl)-4'-α-methylthymidine (E)- and (Z)-5-(2-bromovinyl)-1-(5-chloro-2,5-dideoxy-β-D-erythro-pentofuranosyl)-5-methyl-4-(1,2,4-triazol-1-yl)pyrimidin-2(1H)-one N-<1,2,5-trideoxy-1β-(5-fluoro-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-1-yl)-D-ribofuranos-5-yl>succinamic acid N-butyl-N'-<1,2,5-trideoxy-1β-(5-fluoro-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-1-yl)-D-ribofuranose-5-yl>maleamide N-<1,2,5-trideoxy-1β-(5-fluoro-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-1-yl)-D-ribofuranos-5-yl>maleamic acid 4'-chloromethyl-2'-deoxy-2',2'-difluorocytidine 4'-chloromethyl-2'-deoxy-2'-fluoro-3'-O-(L-valinyl)cytidine dihydrochloride 5'-deoxy-5'-{4-[2-(3-oxo-3H-benzo[f]chromen-1-yl)acetamidomethyl]-1H-1,2,3-triazol-1-yl}thymidine N6-benzoyl-3'-O-t-butyldimethylsilyl-5'-sulfamoylazido-2',5'-dideoxyadenosine N-{9-[(2R,4S,5R)-5-(Acetylamino-methyl)-4-hydroxy-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide